Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs) Meeting Abstract


Authors: Raj, N.; Cruz, E.; Chou, J.; Capanu, M.; DeMore, A.; Hauser, H.; Heffernan, O.; Le, T.; Saltz, L.; Reidy-Lagunes, D.
Abstract Title: Randomized blinded study comparing injection site pain from octreotide long-acting-release (LAR) versus lanreotide during the treatment of well- differentiated neuroendocrine tumors (WDNETs)
Meeting Title: 14th Annual Multidisciplinary Neuroendocrine Tumor Medical Virtual Symposium of the North American Neuroendocrine Tumor Society (NANETS 2021)
Journal Title: Pancreas
Volume: 51
Issue: 3
Meeting Dates: 2021 Nov 4-6
Meeting Location: Virtual
ISSN: 0885-3177
Publisher: Lippincott Williams & Wilkins  
Date Published: 2022-03-01
Start Page: E41
Language: English
ACCESSION: WOS:000819123700051
PROVIDER: wos
PUBMED: 35584389
DOI: 10.1097/MPA.0000000000001979
Notes: Meeting Abstract: C-20 -- Located in section labeled "Clinical" -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Joanne Fu-Lou Chou
    331 Chou
  2. Leonard B Saltz
    790 Saltz
  3. Marinela Capanu
    385 Capanu
  4. Diane Lauren Reidy
    294 Reidy
  5. Nitya Prabhakar Raj
    106 Raj
  6. Elizabeth Maria Cruz
    7 Cruz
  7. Haley Frances Hauser
    18 Hauser
  8. Tiffany Le
    20 Le
  9. April Nicole DeMore
    9 DeMore